ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,453,121 | +9.4% | 602,874 | +4.2% | 0.02% | +14.3% |
| Q2 2023 | $51,621,040 | -6.5% | 578,387 | +12.3% | 0.02% | -12.5% |
| Q1 2023 | $55,224,519 | -7.7% | 515,058 | +5.1% | 0.02% | -11.1% |
| Q4 2022 | $59,837,105 | -9.4% | 489,946 | -23.4% | 0.03% | -15.6% |
| Q3 2022 | $66,074,000 | +3.9% | 639,876 | -6.4% | 0.03% | +10.3% |
| Q2 2022 | $63,566,000 | -23.6% | 683,796 | -3.5% | 0.03% | -9.4% |
| Q1 2022 | $83,194,000 | -12.9% | 708,881 | -0.2% | 0.03% | -5.9% |
| Q4 2021 | $95,537,000 | +7.4% | 710,152 | +27.3% | 0.03% | -2.9% |
| Q3 2021 | $88,929,000 | +16.1% | 557,931 | -4.2% | 0.04% | +12.9% |
| Q2 2021 | $76,614,000 | +24.0% | 582,398 | +21.5% | 0.03% | +14.8% |
| Q1 2021 | $61,778,000 | -19.9% | 479,342 | +3.6% | 0.03% | -25.0% |
| Q4 2020 | $77,141,000 | +6.7% | 462,533 | -1.3% | 0.04% | -7.7% |
| Q3 2020 | $72,299,000 | +9.4% | 468,501 | +4.8% | 0.04% | 0.0% |
| Q2 2020 | $66,116,000 | +16.7% | 447,034 | -11.2% | 0.04% | -4.9% |
| Q1 2020 | $56,672,000 | -24.2% | 503,257 | -6.3% | 0.04% | -2.4% |
| Q4 2019 | $74,719,000 | +45.0% | 537,086 | +0.4% | 0.04% | +31.2% |
| Q3 2019 | $51,545,000 | -11.1% | 535,146 | +6.3% | 0.03% | -11.1% |
| Q2 2019 | $57,967,000 | -19.4% | 503,405 | -17.6% | 0.04% | -23.4% |
| Q1 2019 | $71,898,000 | +67.1% | 610,854 | -11.0% | 0.05% | +46.9% |
| Q4 2018 | $43,018,000 | -15.0% | 686,644 | -3.9% | 0.03% | -3.0% |
| Q3 2018 | $50,620,000 | +9.4% | 714,366 | +2.7% | 0.03% | +3.1% |
| Q2 2018 | $46,253,000 | -3.6% | 695,327 | -5.2% | 0.03% | -8.6% |
| Q1 2018 | $47,963,000 | +2055.6% | 733,383 | +1220.5% | 0.04% | +1650.0% |
| Q4 2017 | $2,225,000 | +104.5% | 55,540 | +85.1% | 0.00% | +100.0% |
| Q3 2017 | $1,088,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |